< back to Directors and Advisors

Charles Meshul, Ph.D.
Dr. Meshul is Professor, Department of Behavioral Neuroscience, Oregon Health & Science University and Research Biologist and Director, Electron Microscopy Facility, Veterans Hospital, Portland, OR. After receiving a PhD in the Department of Anatomy and Cell Biology at the University of Illinois Medical Center, with an emphasis in neuroanatomy and electron microscopy, Dr. Meshul’s postdoctoral fellowship was carried out in the Dept of Pharmacology at the University of Maryland Medical Center, with an emphasis in neurotoxins and electron microscopy. In 1984, Dr. Meshul started at the Portland, VA Medical Center and Oregon Health & Science University in Portland, OR, where he developed an interest in the effects of neuroleptic drugs on the basal ganglia, utilizing both electron microscopy and pharmacology. In the late 1990’s, Dr. Meshul switched to studying Parkinson’s disease (PD) in both rat and mouse models. Using the toxin, MPTP, he has recently developed a new progressive mouse model of PD, whereby increasing the weekly dose of this toxin leads to a gradual loss of dopamine neurons, which correlates with deficits in motor function. With this model he has been able to test various treatments to determine if they can either slow or reverse the effects of the progressive loss of dopamine as seen in humans with PD.

 


  » Home
» News & Events
» Contact Us
ABOUT US
Management Team
Directors & Advisors
Collaborators
Memberships
TECHNOLOGY
Neurogenesis
Drug Discovery
Intellectual Property
R&D PROGRAMS
Alzheimer's Disease (AD)
Depression
Parkinson's Disease (PD)
Down Syndrome
Ischemia
Hibernation and Ischemia
  © 2014 NeuroNascent, Inc. - All Rights Reserved - Website by TeraMark
This website contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as “would,” “may,” “will,” “expects,” and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this site and involve risks and uncertainties that could cause actual results to differ materially from current expectations.